PATENT CLAIM ANALYSIS

Application Number: 15744502
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "291000"]

Abstract:
The present invention relates to the field of tissue injury. More specifically, the present invention provides pharmaceutical compositions useful for the treatment of tissue injury. In certain embodiments, a pharmaceutical composition comprises (a) a stem cell mobilizer and (b) an immunosuppressive agent or non-immunosuppressive FK binding protein ligand. The pharmaceutical compositions of the invention can be administered by a variety of routes and dosing regimens.

Claim (Index 2):
The pharmaceutical composition of  claim 1 , wherein the pharmaceutical composition is formulated for subcutaneous or intramuscular injection.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14814988', '14006053', '12747302', '14126768', '13518513']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7804665965863039
- 35 USC 102 Novelty (BERT): 0.5483004788407442
- Combined Prediction Score: 0.757249984811748
- Mean Citation Score: 290.261294
- Max Citation Score: 420.67328
- Similarity Product: 272.2645561451721

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test